ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Realities Of The 1989 Budget: Number Of grants Cut By 250, Only 255 Of Approved Will By Funded

October 7, 1988

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies.

April 30, 2004